Speakers

AviadoBio

At AviadoBio our mission is to transform the lives of patients living with and suffering from neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

Our industry-leading science and technology is based on pioneering research from King’s College London and the UK Dementia Research Institute, co-founded by Prof. Christopher Shaw, Dr. Youn Bok Lee and Dr. Do Young Lee and is supported by leading life sciences investors.

We are building world-class capabilities to discover, develop, manufacture and commercialize gene therapy products.